NO991548L - Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer - Google Patents

Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer

Info

Publication number
NO991548L
NO991548L NO991548A NO991548A NO991548L NO 991548 L NO991548 L NO 991548L NO 991548 A NO991548 A NO 991548A NO 991548 A NO991548 A NO 991548A NO 991548 L NO991548 L NO 991548L
Authority
NO
Norway
Prior art keywords
mupirocin
nasopharynx
colonization
drug
manufacture
Prior art date
Application number
NO991548A
Other languages
English (en)
Other versions
NO991548D0 (no
Inventor
Anthony Guy Hatton
Timothy John Henkel
Jane Elizabeth Hilton
Hugh Purdie Scott
Teresita Regina Geradin Tallon
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9716805.8A external-priority patent/GB9716805D0/en
Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of NO991548D0 publication Critical patent/NO991548D0/no
Publication of NO991548L publication Critical patent/NO991548L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mupirocin eller et salt eller ester derav kan anvendes til å behandle gjentatt sinusitt og gjentatt otitt, spesielt med nye spray- eller kremformuleringer tilpasset for administrering til nasofarynks.
NO991548A 1996-10-01 1999-03-30 Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer NO991548L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2722496P 1996-10-01 1996-10-01
US2722396P 1996-10-01 1996-10-01
US2722296P 1996-10-01 1996-10-01
GBGB9716805.8A GB9716805D0 (en) 1997-08-09 1997-08-09 Novel composition and use
GBGB9719203.3A GB9719203D0 (en) 1997-09-11 1997-09-11 Novel composition and use
PCT/GB1997/002664 WO1998014189A1 (en) 1996-10-01 1997-09-29 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Publications (2)

Publication Number Publication Date
NO991548D0 NO991548D0 (no) 1999-03-30
NO991548L true NO991548L (no) 1999-03-31

Family

ID=27517419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991548A NO991548L (no) 1996-10-01 1999-03-30 Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer

Country Status (17)

Country Link
US (1) US6001870A (no)
EP (1) EP0939631A1 (no)
JP (1) JP2001504091A (no)
KR (1) KR20000048812A (no)
CN (1) CN1239427A (no)
AR (1) AR010995A1 (no)
AU (1) AU724070B2 (no)
BR (1) BR9711843A (no)
CA (1) CA2267248A1 (no)
CZ (1) CZ112499A3 (no)
HU (1) HUP9904308A3 (no)
IL (1) IL129237A0 (no)
NO (1) NO991548L (no)
NZ (1) NZ334913A (no)
PL (1) PL332642A1 (no)
TR (1) TR199900733T2 (no)
WO (1) WO1998014189A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001504091A (ja) * 1996-10-01 2001-03-27 スミスクライン・ビーチャム・コーポレイション 病原性生物による鼻咽腔のコロニー形成に関連する細菌感染の治療のための薬剤の製造のためのミュピロシンの使用
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
JP2001513493A (ja) * 1997-08-09 2001-09-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 経鼻投与用組成物
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
GB9902138D0 (en) 1999-02-02 1999-03-24 Smithkline Beecham Container
CN1670217A (zh) * 1999-02-03 2005-09-21 特瓦药厂有限公司 经微生物学方法制备假单胞菌酸a抗生素的方法
AU5397300A (en) * 1999-06-02 2000-12-28 Hexal Ag Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
HUP0500797A2 (en) * 2001-06-21 2007-06-28 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
EP1455769A4 (en) 2001-12-28 2004-09-22 Biogal Gyogyszergyar METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
ATE458476T1 (de) * 2004-06-01 2010-03-15 Teva Gyogyszergyar Zartkoeruen Verfahren für die zubereitung der amorphen form eines medikamentes
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
MX2007010908A (es) 2005-03-10 2007-12-05 3M Innovative Properties Co Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos.
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
US20100021563A1 (en) * 2008-07-24 2010-01-28 Paul Levesque Compositions comprising coconut oil and methods of use thereof
EP2346324A4 (en) 2008-10-06 2012-10-10 Microbial Defense Systems Llc ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
EP3456200B1 (en) 2011-05-10 2023-05-03 Next Science IP Holdings Pty Ltd Article having an antimicrobial solid and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
KR100374462B1 (ko) * 1993-10-22 2003-06-09 스미스클라인 비참 코포레이션 신규조성물
JP2001504091A (ja) * 1996-10-01 2001-03-27 スミスクライン・ビーチャム・コーポレイション 病原性生物による鼻咽腔のコロニー形成に関連する細菌感染の治療のための薬剤の製造のためのミュピロシンの使用

Also Published As

Publication number Publication date
JP2001504091A (ja) 2001-03-27
TR199900733T2 (xx) 1999-07-21
HUP9904308A2 (hu) 2001-04-28
PL332642A1 (en) 1999-09-27
AU4562397A (en) 1998-04-24
AU724070B2 (en) 2000-09-14
NO991548D0 (no) 1999-03-30
WO1998014189A1 (en) 1998-04-09
AR010995A1 (es) 2000-08-02
BR9711843A (pt) 2001-07-31
CN1239427A (zh) 1999-12-22
IL129237A0 (en) 2000-02-17
HUP9904308A3 (en) 2002-06-28
CZ112499A3 (cs) 1999-08-11
US6001870A (en) 1999-12-14
NZ334913A (en) 2001-03-30
KR20000048812A (ko) 2000-07-25
EP0939631A1 (en) 1999-09-08
CA2267248A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
NO991548D0 (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
AU2722495A (en) Intermediates for the manufacture of 6-fluoro-1,4-dihydro-4- oxo-3-quinoline carboxylic acids
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
AU3311095A (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
IL100100A0 (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
NO963446L (no) Surgjort nitritt som et antimikrobielt middel
ATE461928T1 (de) Antibakterielle wirkstoffe
ATE274916T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
DE69939722D1 (de) Fulvinsäure und deren Verwendung in der Behandlung von Entzündungen
DE122011100013I1 (de) Makrolid-antibiotika und behandlung von pasteurellosis.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
Ravishankar et al. In vitro antibacterial efficacy of sutures coated with Aloe vera and ciprofloxacin: a comparative evaluation
ES2133722T3 (es) Utilizacion de dextranos simples o conjugados para la fabricacion de un medicamento para prevenir o reducir el riesgo de infeccion de germenes patogenos bacterianos.
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
ATE457730T1 (de) Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen
HUP0401586A2 (hu) Baktériumellenes szer
DK1232173T3 (da) Nye fusidinsyrederivater
ES466645A1 (es) Un procedimiento para la produccion de desacetildihidro 890a9
SV1994000023A (es) Pirroles sustituidos ref. ran 4070/90
HK1022629A (en) Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application